Rank | Gene Set | Z-score |
---|---|---|
1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 8.43966430 |
2 | central nervous system myelination (GO:0022010) | 7.46145382 |
3 | axon ensheathment in central nervous system (GO:0032291) | 7.46145382 |
4 | sodium ion export (GO:0071436) | 6.28821362 |
5 | neuronal action potential propagation (GO:0019227) | 5.37174131 |
6 | positive regulation of synapse maturation (GO:0090129) | 5.20824010 |
7 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.81353023 |
8 | neurotransmitter transport (GO:0006836) | 4.71854793 |
9 | ensheathment of neurons (GO:0007272) | 4.69514010 |
10 | axon ensheathment (GO:0008366) | 4.69514010 |
11 | myelination (GO:0042552) | 4.67382582 |
12 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.63720621 |
13 | fatty acid elongation (GO:0030497) | 4.53388468 |
14 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.41188465 |
15 | potassium ion homeostasis (GO:0055075) | 4.38235112 |
16 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.29245696 |
17 | postsynaptic membrane organization (GO:0001941) | 4.27139564 |
18 | potassium ion import (GO:0010107) | 4.26857221 |
19 | regulation of neurotransmitter levels (GO:0001505) | 4.21270483 |
20 | neuron cell-cell adhesion (GO:0007158) | 4.20009682 |
21 | establishment of mitochondrion localization (GO:0051654) | 4.16876090 |
22 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.14139010 |
23 | neurofilament cytoskeleton organization (GO:0060052) | 4.08729494 |
24 | regulation of synapse maturation (GO:0090128) | 4.08380078 |
25 | cellular sodium ion homeostasis (GO:0006883) | 4.07364081 |
26 | regulation of neurotransmitter secretion (GO:0046928) | 4.07203720 |
27 | presynaptic membrane organization (GO:0097090) | 4.07089992 |
28 | cell communication by electrical coupling (GO:0010644) | 4.06533688 |
29 | proline transport (GO:0015824) | 4.06507458 |
30 | synaptic vesicle maturation (GO:0016188) | 3.96412534 |
31 | synaptic vesicle endocytosis (GO:0048488) | 3.94911675 |
32 | regulation of vesicle fusion (GO:0031338) | 3.93562715 |
33 | synaptic vesicle exocytosis (GO:0016079) | 3.88622096 |
34 | presynaptic membrane assembly (GO:0097105) | 3.87417465 |
35 | L-amino acid import (GO:0043092) | 3.83385860 |
36 | transmission of nerve impulse (GO:0019226) | 3.79742808 |
37 | negative regulation of neurotransmitter transport (GO:0051589) | 3.79700316 |
38 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.77377409 |
39 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.75321405 |
40 | regulation of neurotransmitter transport (GO:0051588) | 3.70958737 |
41 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.70465967 |
42 | adult walking behavior (GO:0007628) | 3.66767098 |
43 | regulation of ARF protein signal transduction (GO:0032012) | 3.64610403 |
44 | glutamate secretion (GO:0014047) | 3.55097497 |
45 | vocalization behavior (GO:0071625) | 3.54128488 |
46 | positive regulation of dendritic spine development (GO:0060999) | 3.53414445 |
47 | layer formation in cerebral cortex (GO:0021819) | 3.51774904 |
48 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.50027141 |
49 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.47707512 |
50 | neurotransmitter uptake (GO:0001504) | 3.47060925 |
51 | regulation of synapse structural plasticity (GO:0051823) | 3.47030853 |
52 | auditory behavior (GO:0031223) | 3.44206897 |
53 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.43156543 |
54 | locomotory exploration behavior (GO:0035641) | 3.42593763 |
55 | serotonin metabolic process (GO:0042428) | 3.41269889 |
56 | cell differentiation in hindbrain (GO:0021533) | 3.40836177 |
57 | protein localization to synapse (GO:0035418) | 3.40173353 |
58 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.39159056 |
59 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.35665166 |
60 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.35203456 |
61 | positive regulation of neurotransmitter transport (GO:0051590) | 3.34649637 |
62 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.34331723 |
63 | apical protein localization (GO:0045176) | 3.33937520 |
64 | myelin maintenance (GO:0043217) | 3.33490982 |
65 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.30752631 |
66 | cell communication involved in cardiac conduction (GO:0086065) | 3.29201334 |
67 | neuron recognition (GO:0008038) | 3.28454187 |
68 | glutamate receptor signaling pathway (GO:0007215) | 3.28304830 |
69 | negative regulation of protein localization to cell surface (GO:2000009) | 3.27971757 |
70 | neuronal ion channel clustering (GO:0045161) | 3.27715708 |
71 | neuromuscular process controlling posture (GO:0050884) | 3.26546242 |
72 | * synaptic transmission (GO:0007268) | 3.25552675 |
73 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.24291185 |
74 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.23553894 |
75 | regulation of synaptic transmission (GO:0050804) | 3.23316040 |
76 | neuromuscular process (GO:0050905) | 3.22683584 |
77 | long-term synaptic potentiation (GO:0060291) | 3.21444486 |
78 | cerebellar granule cell differentiation (GO:0021707) | 3.20807817 |
79 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.20436895 |
80 | neuron-neuron synaptic transmission (GO:0007270) | 3.18870022 |
81 | gamma-aminobutyric acid transport (GO:0015812) | 3.18824306 |
82 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.18569373 |
83 | synaptic transmission, glutamatergic (GO:0035249) | 3.18447700 |
84 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.17868109 |
85 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.17868109 |
86 | cell migration in hindbrain (GO:0021535) | 3.17542739 |
87 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.17470787 |
88 | neuromuscular synaptic transmission (GO:0007274) | 3.14906945 |
89 | response to auditory stimulus (GO:0010996) | 3.12968918 |
90 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.12079548 |
91 | signal release (GO:0023061) | 3.11977876 |
92 | establishment of synaptic vesicle localization (GO:0097480) | 3.08712324 |
93 | synaptic vesicle transport (GO:0048489) | 3.08712324 |
94 | axon development (GO:0061564) | 3.07107262 |
95 | acidic amino acid transport (GO:0015800) | 3.07080114 |
96 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.05092082 |
97 | axonal fasciculation (GO:0007413) | 3.04593979 |
98 | detection of calcium ion (GO:0005513) | 3.04298862 |
99 | nerve growth factor signaling pathway (GO:0038180) | 3.00456427 |
100 | vesicle docking involved in exocytosis (GO:0006904) | 2.99930509 |
101 | detection of temperature stimulus (GO:0016048) | 2.99908108 |
102 | cellular potassium ion homeostasis (GO:0030007) | 2.99742816 |
103 | oligodendrocyte differentiation (GO:0048709) | 2.99463960 |
104 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.98906750 |
105 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.96625840 |
106 | mitochondrion transport along microtubule (GO:0047497) | 2.96625840 |
107 | response to methylmercury (GO:0051597) | 2.94964676 |
108 | glycerophospholipid catabolic process (GO:0046475) | 2.91976363 |
109 | asymmetric protein localization (GO:0008105) | 2.91518222 |
110 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.91477382 |
111 | dendritic spine morphogenesis (GO:0060997) | 2.90436288 |
112 | positive regulation of potassium ion transport (GO:0043268) | 2.88617125 |
113 | exploration behavior (GO:0035640) | 2.88589794 |
114 | glycine transport (GO:0015816) | 2.88257782 |
115 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.87582645 |
116 | amino acid import (GO:0043090) | 2.84921495 |
117 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.84693707 |
118 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.84681834 |
119 | negative regulation of axonogenesis (GO:0050771) | 2.84651532 |
120 | neuromuscular process controlling balance (GO:0050885) | 2.84642088 |
121 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.84557279 |
122 | regulation of synaptic vesicle transport (GO:1902803) | 2.84276563 |
123 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.82703188 |
124 | dendrite morphogenesis (GO:0048813) | 2.78405642 |
125 | membrane depolarization during action potential (GO:0086010) | 2.76131921 |
126 | positive regulation of membrane potential (GO:0045838) | 2.75743027 |
127 | organelle transport along microtubule (GO:0072384) | 2.74795767 |
128 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.72890408 |
129 | regulation of postsynaptic membrane potential (GO:0060078) | 2.72319808 |
130 | regulation of dendritic spine development (GO:0060998) | 2.71367737 |
131 | membrane hyperpolarization (GO:0060081) | 2.71284992 |
132 | regulation of collateral sprouting (GO:0048670) | 2.70228515 |
133 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.69891388 |
134 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.68925688 |
135 | regulation of synaptic plasticity (GO:0048167) | 2.68150900 |
136 | neurotransmitter secretion (GO:0007269) | 2.67091061 |
137 | photoreceptor cell differentiation (GO:0046530) | 2.65653781 |
138 | eye photoreceptor cell differentiation (GO:0001754) | 2.65653781 |
139 | membrane depolarization (GO:0051899) | 2.65477844 |
140 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.65039207 |
141 | astrocyte development (GO:0014002) | 2.65038103 |
142 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.61184839 |
143 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.61119287 |
144 | neuron remodeling (GO:0016322) | 2.61027042 |
145 | neuronal action potential (GO:0019228) | 2.60907412 |
146 | long-term memory (GO:0007616) | 2.60508731 |
147 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.60084754 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.61310006 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.77722922 |
3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.99785732 |
4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.97230395 |
5 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.93955887 |
6 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.62513327 |
7 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.62513327 |
8 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.47456633 |
9 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.42738630 |
10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.40885018 |
11 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.39872013 |
12 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.38755183 |
13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.35087366 |
14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.34059632 |
15 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.32137533 |
16 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.18575858 |
17 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.15708778 |
18 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.11917598 |
19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.09659474 |
20 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.03897645 |
21 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.02772396 |
22 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.96610367 |
23 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.95760174 |
24 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.95610639 |
25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.88723244 |
26 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.78413543 |
27 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.76693068 |
28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.73255909 |
29 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.66589153 |
30 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.64023675 |
31 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.63564959 |
32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.61263725 |
33 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.56906537 |
34 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.55481078 |
35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.53302324 |
36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.50566144 |
37 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.49295971 |
38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.49208644 |
39 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.48097869 |
40 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.47920766 |
41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.47337562 |
42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.46018342 |
43 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.42034383 |
44 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.41371307 |
45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.41289871 |
46 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40802464 |
47 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.35935000 |
48 | STAT3_23295773_ChIP-Seq_U87_Human | 1.31652525 |
49 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.30373898 |
50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.28481807 |
51 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.28159490 |
52 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.27960683 |
53 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.27289344 |
54 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.27024555 |
55 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.26989826 |
56 | KDM2B_26808549_Chip-Seq_K562_Human | 1.26319502 |
57 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.23748785 |
58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.23101928 |
59 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21702805 |
60 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20687739 |
61 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.19841407 |
62 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.17607954 |
63 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17347553 |
64 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.16732002 |
65 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14639438 |
66 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.13993365 |
67 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13861059 |
68 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.13423881 |
69 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12756247 |
70 | VDR_22108803_ChIP-Seq_LS180_Human | 1.12701035 |
71 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.12006215 |
72 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.11105446 |
73 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10847719 |
74 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09884475 |
75 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.09814827 |
76 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.09628135 |
77 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.08308993 |
78 | TP53_16413492_ChIP-PET_HCT116_Human | 1.08134933 |
79 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.07846963 |
80 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.07649818 |
81 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.07236946 |
82 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07067677 |
83 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.07056541 |
84 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.06908213 |
85 | AR_25329375_ChIP-Seq_VCAP_Human | 1.05921938 |
86 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05648934 |
87 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05434743 |
88 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04597764 |
89 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04275165 |
90 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03466605 |
91 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02559843 |
92 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.02237531 |
93 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.02041877 |
94 | FUS_26573619_Chip-Seq_HEK293_Human | 1.00862028 |
95 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.00004452 |
96 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.99589256 |
97 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98091298 |
98 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96803817 |
99 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96803817 |
100 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.96780675 |
101 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96046964 |
102 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95872750 |
103 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95754848 |
104 | AR_19668381_ChIP-Seq_PC3_Human | 0.95733576 |
105 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.94000990 |
106 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93639437 |
107 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.93400242 |
108 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92466998 |
109 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.91497819 |
110 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.91159659 |
111 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.90966313 |
112 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90911613 |
113 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90247227 |
114 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90247227 |
115 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90242917 |
116 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.89688632 |
117 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88128875 |
118 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87946533 |
119 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87655487 |
120 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.86971085 |
121 | KDM2B_26808549_Chip-Seq_REH_Human | 0.86853281 |
122 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.86807344 |
123 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.84656287 |
124 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.84014009 |
125 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.83613444 |
126 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.83463530 |
127 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.82767054 |
128 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.82664330 |
129 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.81622822 |
130 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80419616 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 4.85412256 |
2 | MP0003880_abnormal_central_pattern | 4.82474341 |
3 | MP0004270_analgesia | 4.38606336 |
4 | MP0000920_abnormal_myelination | 3.55232165 |
5 | * MP0003635_abnormal_synaptic_transmissio | 3.27710036 |
6 | * MP0002272_abnormal_nervous_system | 3.00618377 |
7 | * MP0002064_seizures | 2.91655325 |
8 | * MP0009046_muscle_twitch | 2.87575617 |
9 | * MP0009745_abnormal_behavioral_response | 2.74740666 |
10 | MP0002734_abnormal_mechanical_nocicepti | 2.73044703 |
11 | * MP0001486_abnormal_startle_reflex | 2.67868157 |
12 | MP0003329_amyloid_beta_deposits | 2.64996867 |
13 | MP0001968_abnormal_touch/_nociception | 2.54609419 |
14 | MP0002063_abnormal_learning/memory/cond | 2.52229032 |
15 | MP0002572_abnormal_emotion/affect_behav | 2.27812439 |
16 | * MP0002735_abnormal_chemical_nociception | 2.26178310 |
17 | MP0005423_abnormal_somatic_nervous | 2.24890605 |
18 | MP0002736_abnormal_nociception_after | 2.13861380 |
19 | MP0003690_abnormal_glial_cell | 2.12178825 |
20 | MP0008569_lethality_at_weaning | 2.09664433 |
21 | MP0000778_abnormal_nervous_system | 2.07359583 |
22 | MP0004142_abnormal_muscle_tone | 2.05349280 |
23 | MP0001440_abnormal_grooming_behavior | 2.01826425 |
24 | * MP0002067_abnormal_sensory_capabilities | 2.01430715 |
25 | MP0001529_abnormal_vocalization | 2.01162493 |
26 | MP0004885_abnormal_endolymph | 2.00837274 |
27 | MP0004742_abnormal_vestibular_system | 1.92831893 |
28 | * MP0001970_abnormal_pain_threshold | 1.89125787 |
29 | MP0000955_abnormal_spinal_cord | 1.88641524 |
30 | * MP0002733_abnormal_thermal_nociception | 1.78173570 |
31 | MP0002229_neurodegeneration | 1.76436701 |
32 | MP0001485_abnormal_pinna_reflex | 1.74145355 |
33 | MP0005171_absent_coat_pigmentation | 1.73157061 |
34 | MP0002184_abnormal_innervation | 1.72153289 |
35 | * MP0003634_abnormal_glial_cell | 1.71408651 |
36 | MP0001501_abnormal_sleep_pattern | 1.68342406 |
37 | MP0005409_darkened_coat_color | 1.67659954 |
38 | MP0001905_abnormal_dopamine_level | 1.67000348 |
39 | MP0003787_abnormal_imprinting | 1.65314843 |
40 | MP0002882_abnormal_neuron_morphology | 1.61963213 |
41 | MP0003632_abnormal_nervous_system | 1.57987070 |
42 | MP0002822_catalepsy | 1.55955003 |
43 | MP0006276_abnormal_autonomic_nervous | 1.53471471 |
44 | MP0004858_abnormal_nervous_system | 1.52519761 |
45 | MP0004145_abnormal_muscle_electrophysio | 1.52245813 |
46 | * MP0002066_abnormal_motor_capabilities/c | 1.51921727 |
47 | MP0003950_abnormal_plasma_membrane | 1.50857820 |
48 | MP0003631_nervous_system_phenotype | 1.49451293 |
49 | MP0003633_abnormal_nervous_system | 1.48413130 |
50 | * MP0005386_behavior/neurological_phenoty | 1.39712871 |
51 | * MP0004924_abnormal_behavior | 1.39712871 |
52 | MP0004811_abnormal_neuron_physiology | 1.37847679 |
53 | MP0000604_amyloidosis | 1.29298548 |
54 | MP0003136_yellow_coat_color | 1.27546542 |
55 | MP0005167_abnormal_blood-brain_barrier | 1.26411267 |
56 | MP0003123_paternal_imprinting | 1.24450190 |
57 | MP0005410_abnormal_fertilization | 1.21360103 |
58 | * MP0002557_abnormal_social/conspecific_i | 1.20086049 |
59 | * MP0001963_abnormal_hearing_physiology | 1.19817218 |
60 | MP0002752_abnormal_somatic_nervous | 1.19733049 |
61 | MP0003122_maternal_imprinting | 1.18882113 |
62 | MP0001299_abnormal_eye_distance/ | 1.15154018 |
63 | MP0005551_abnormal_eye_electrophysiolog | 1.12834589 |
64 | MP0004043_abnormal_pH_regulation | 1.10860157 |
65 | MP0009780_abnormal_chondrocyte_physiolo | 1.10857918 |
66 | MP0000747_muscle_weakness | 1.08031899 |
67 | MP0000751_myopathy | 1.01317854 |
68 | * MP0002152_abnormal_brain_morphology | 1.00720219 |
69 | MP0005646_abnormal_pituitary_gland | 0.98597064 |
70 | MP0001188_hyperpigmentation | 0.97637252 |
71 | MP0001502_abnormal_circadian_rhythm | 0.97521402 |
72 | MP0005623_abnormal_meninges_morphology | 0.96155187 |
73 | MP0003879_abnormal_hair_cell | 0.88900233 |
74 | MP0001177_atelectasis | 0.86740607 |
75 | MP0002638_abnormal_pupillary_reflex | 0.83937191 |
76 | MP0010386_abnormal_urinary_bladder | 0.83929635 |
77 | MP0000462_abnormal_digestive_system | 0.83764058 |
78 | MP0001346_abnormal_lacrimal_gland | 0.83348379 |
79 | MP0005645_abnormal_hypothalamus_physiol | 0.81012484 |
80 | MP0008260_abnormal_autophagy | 0.80917394 |
81 | MP0003075_altered_response_to | 0.80136907 |
82 | MP0001984_abnormal_olfaction | 0.79908455 |
83 | MP0008877_abnormal_DNA_methylation | 0.78527360 |
84 | MP0001986_abnormal_taste_sensitivity | 0.78305329 |
85 | MP0000026_abnormal_inner_ear | 0.78191880 |
86 | MP0008874_decreased_physiological_sensi | 0.74744717 |
87 | MP0003045_fibrosis | 0.73669139 |
88 | MP0003938_abnormal_ear_development | 0.70606678 |
89 | MP0002069_abnormal_eating/drinking_beha | 0.68497011 |
90 | MP0002909_abnormal_adrenal_gland | 0.68441323 |
91 | MP0004134_abnormal_chest_morphology | 0.65843960 |
92 | MP0000569_abnormal_digit_pigmentation | 0.65555580 |
93 | MP0000749_muscle_degeneration | 0.64240517 |
94 | * MP0004085_abnormal_heartbeat | 0.63905681 |
95 | MP0004130_abnormal_muscle_cell | 0.62401940 |
96 | MP0005195_abnormal_posterior_eye | 0.60877543 |
97 | MP0002751_abnormal_autonomic_nervous | 0.60253559 |
98 | MP0001943_abnormal_respiration | 0.59380484 |
99 | MP0002090_abnormal_vision | 0.58453449 |
100 | MP0000579_abnormal_nail_morphology | 0.58099027 |
101 | MP0004036_abnormal_muscle_relaxation | 0.57827300 |
102 | MP0001664_abnormal_digestion | 0.56348806 |
103 | * MP0010768_mortality/aging | 0.55941629 |
104 | MP0010678_abnormal_skin_adnexa | 0.55888839 |
105 | * MP0002082_postnatal_lethality | 0.54732992 |
106 | MP0008872_abnormal_physiological_respon | 0.53901710 |
107 | MP0004381_abnormal_hair_follicle | 0.53158741 |
108 | MP0000631_abnormal_neuroendocrine_gland | 0.52840127 |
109 | * MP0003956_abnormal_body_size | 0.51600709 |
110 | * MP0003861_abnormal_nervous_system | 0.51544637 |
111 | MP0005535_abnormal_body_temperature | 0.51356826 |
112 | MP0001765_abnormal_ion_homeostasis | 0.51184933 |
113 | MP0002295_abnormal_pulmonary_circulatio | 0.50224428 |
114 | MP0004215_abnormal_myocardial_fiber | 0.50200120 |
115 | MP0004510_myositis | 0.50151715 |
116 | * MP0010769_abnormal_survival | 0.49536559 |
117 | * MP0003137_abnormal_impulse_conducting | 0.48822762 |
118 | MP0004484_altered_response_of | 0.46776180 |
119 | * MP0010770_preweaning_lethality | 0.46559249 |
120 | MP0000639_abnormal_adrenal_gland | 0.44285862 |
121 | MP0002873_normal_phenotype | 0.42280716 |
122 | MP0003283_abnormal_digestive_organ | 0.41077785 |
123 | MP0003172_abnormal_lysosome_physiology | 0.40469048 |
124 | MP0002169_no_abnormal_phenotype | 0.40459765 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 5.72142157 |
2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.21121240 |
3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.21121240 |
4 | Action tremor (HP:0002345) | 4.58030569 |
5 | Neurofibrillary tangles (HP:0002185) | 4.55112431 |
6 | Abnormality of the corticospinal tract (HP:0002492) | 4.46731668 |
7 | Supranuclear gaze palsy (HP:0000605) | 4.40343291 |
8 | * Myokymia (HP:0002411) | 4.37583148 |
9 | Insidious onset (HP:0003587) | 4.15031804 |
10 | Termporal pattern (HP:0011008) | 4.15031804 |
11 | Papilledema (HP:0001085) | 4.10342159 |
12 | Scanning speech (HP:0002168) | 4.06603947 |
13 | Peripheral hypomyelination (HP:0007182) | 4.03534459 |
14 | Focal seizures (HP:0007359) | 3.98858411 |
15 | Onion bulb formation (HP:0003383) | 3.93318019 |
16 | Atonic seizures (HP:0010819) | 3.86089324 |
17 | Ulnar claw (HP:0001178) | 3.85899196 |
18 | Dysmetria (HP:0001310) | 3.84216342 |
19 | Hemiplegia (HP:0002301) | 3.82937576 |
20 | Obstructive sleep apnea (HP:0002870) | 3.77928426 |
21 | Ankle clonus (HP:0011448) | 3.55367623 |
22 | Cerebral inclusion bodies (HP:0100314) | 3.49899181 |
23 | Epileptic encephalopathy (HP:0200134) | 3.43255015 |
24 | Status epilepticus (HP:0002133) | 3.40647177 |
25 | Sensory axonal neuropathy (HP:0003390) | 3.38413537 |
26 | Intention tremor (HP:0002080) | 3.35665054 |
27 | Annular pancreas (HP:0001734) | 3.35532371 |
28 | Progressive cerebellar ataxia (HP:0002073) | 3.35043318 |
29 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.31650969 |
30 | * Spastic gait (HP:0002064) | 3.23780918 |
31 | Tetraplegia (HP:0002445) | 3.19253376 |
32 | Gaze-evoked nystagmus (HP:0000640) | 3.14863293 |
33 | Epileptiform EEG discharges (HP:0011182) | 3.10660384 |
34 | Parakeratosis (HP:0001036) | 3.04299163 |
35 | Focal dystonia (HP:0004373) | 3.03142844 |
36 | Impaired smooth pursuit (HP:0007772) | 3.02385909 |
37 | Febrile seizures (HP:0002373) | 2.99222548 |
38 | Limb dystonia (HP:0002451) | 2.99152852 |
39 | Pheochromocytoma (HP:0002666) | 2.98094238 |
40 | Craniofacial dystonia (HP:0012179) | 2.89728862 |
41 | Bradykinesia (HP:0002067) | 2.87987322 |
42 | Dialeptic seizures (HP:0011146) | 2.87519660 |
43 | Genetic anticipation (HP:0003743) | 2.83478529 |
44 | Dysdiadochokinesis (HP:0002075) | 2.82045989 |
45 | Hammertoe (HP:0001765) | 2.80973196 |
46 | Absence seizures (HP:0002121) | 2.78815459 |
47 | Foot dorsiflexor weakness (HP:0009027) | 2.76803566 |
48 | Broad-based gait (HP:0002136) | 2.76796141 |
49 | Dysmetric saccades (HP:0000641) | 2.72820774 |
50 | Slow saccadic eye movements (HP:0000514) | 2.71952394 |
51 | Truncal ataxia (HP:0002078) | 2.68320654 |
52 | Decreased motor nerve conduction velocity (HP:0003431) | 2.68152545 |
53 | Visual hallucinations (HP:0002367) | 2.66638380 |
54 | Urinary urgency (HP:0000012) | 2.65374151 |
55 | Retinal dysplasia (HP:0007973) | 2.64441647 |
56 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.63352645 |
57 | EEG with generalized epileptiform discharges (HP:0011198) | 2.63272730 |
58 | Neuroendocrine neoplasm (HP:0100634) | 2.63209672 |
59 | Sleep apnea (HP:0010535) | 2.62996968 |
60 | Generalized tonic-clonic seizures (HP:0002069) | 2.57778063 |
61 | Akinesia (HP:0002304) | 2.55636370 |
62 | Steppage gait (HP:0003376) | 2.55360586 |
63 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.52436670 |
64 | Lower limb muscle weakness (HP:0007340) | 2.52146786 |
65 | Abnormal social behavior (HP:0012433) | 2.50694325 |
66 | Impaired social interactions (HP:0000735) | 2.50694325 |
67 | Abnormality of the foot musculature (HP:0001436) | 2.49803089 |
68 | Abnormal auditory evoked potentials (HP:0006958) | 2.46034545 |
69 | Hypsarrhythmia (HP:0002521) | 2.42911401 |
70 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.42277118 |
71 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.41834202 |
72 | Cerebral hypomyelination (HP:0006808) | 2.39356617 |
73 | Abnormality of the lower motor neuron (HP:0002366) | 2.36243457 |
74 | Amblyopia (HP:0000646) | 2.35078135 |
75 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.34214334 |
76 | Rigidity (HP:0002063) | 2.32226007 |
77 | Progressive inability to walk (HP:0002505) | 2.30924501 |
78 | Distal sensory impairment (HP:0002936) | 2.29559543 |
79 | Impaired vibratory sensation (HP:0002495) | 2.29477761 |
80 | Stereotypic behavior (HP:0000733) | 2.28624918 |
81 | Thickened helices (HP:0000391) | 2.24659661 |
82 | Hyperventilation (HP:0002883) | 2.22668321 |
83 | Choreoathetosis (HP:0001266) | 2.21632878 |
84 | Alacrima (HP:0000522) | 2.20969150 |
85 | Anxiety (HP:0000739) | 2.20038646 |
86 | Generalized myoclonic seizures (HP:0002123) | 2.18558945 |
87 | Increased circulating renin level (HP:0000848) | 2.17814202 |
88 | Birth length less than 3rd percentile (HP:0003561) | 2.17198180 |
89 | Cerebral hemorrhage (HP:0001342) | 2.13718271 |
90 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.13358095 |
91 | Insomnia (HP:0100785) | 2.10997593 |
92 | Ventricular fibrillation (HP:0001663) | 2.10831059 |
93 | Hemiparesis (HP:0001269) | 2.10054620 |
94 | Clumsiness (HP:0002312) | 2.09939005 |
95 | Postural instability (HP:0002172) | 2.09435409 |
96 | Abnormality of saccadic eye movements (HP:0000570) | 2.09311760 |
97 | Bundle branch block (HP:0011710) | 2.08660722 |
98 | Clonus (HP:0002169) | 2.08564244 |
99 | Megalencephaly (HP:0001355) | 2.06844155 |
100 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.04149297 |
101 | Aplasia of the phalanges of the hand (HP:0009802) | 2.04149297 |
102 | Aplasia involving bones of the extremities (HP:0009825) | 2.04149297 |
103 | Abnormal eating behavior (HP:0100738) | 2.03405791 |
104 | Incomplete penetrance (HP:0003829) | 2.02552953 |
105 | Depression (HP:0000716) | 2.01938056 |
106 | Apathy (HP:0000741) | 2.01220159 |
107 | CNS hypomyelination (HP:0003429) | 1.99702234 |
108 | Rapidly progressive (HP:0003678) | 1.95198734 |
109 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.94820243 |
110 | Leukodystrophy (HP:0002415) | 1.94343867 |
111 | Lower limb asymmetry (HP:0100559) | 1.93992261 |
112 | Autoamputation (HP:0001218) | 1.93988325 |
113 | Spastic tetraparesis (HP:0001285) | 1.92204651 |
114 | Synostosis involving the elbow (HP:0003938) | 1.89984564 |
115 | Humeroradial synostosis (HP:0003041) | 1.89984564 |
116 | Hypomagnesemia (HP:0002917) | 1.86378999 |
117 | Delusions (HP:0000746) | 1.85569531 |
118 | Bronchomalacia (HP:0002780) | 1.85507798 |
119 | Diplopia (HP:0000651) | 1.85013114 |
120 | Abnormality of binocular vision (HP:0011514) | 1.85013114 |
121 | Absent speech (HP:0001344) | 1.84898895 |
122 | Gait ataxia (HP:0002066) | 1.80718245 |
123 | Split foot (HP:0001839) | 1.80142086 |
124 | Memory impairment (HP:0002354) | 1.79221080 |
125 | Neuronal loss in central nervous system (HP:0002529) | 1.78606493 |
126 | Slow progression (HP:0003677) | 1.76012189 |
127 | Diminished motivation (HP:0000745) | 1.75574938 |
128 | Heart block (HP:0012722) | 1.75443354 |
129 | Poor speech (HP:0002465) | 1.73868703 |
130 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.71865473 |
131 | Anteriorly placed anus (HP:0001545) | 1.71776512 |
132 | Excessive salivation (HP:0003781) | 1.71133329 |
133 | Drooling (HP:0002307) | 1.71133329 |
134 | Torticollis (HP:0000473) | 1.71026869 |
135 | Fetal akinesia sequence (HP:0001989) | 1.70830428 |
136 | Absent septum pellucidum (HP:0001331) | 1.70678579 |
137 | Poor eye contact (HP:0000817) | 1.70224957 |
138 | Mutism (HP:0002300) | 1.69586944 |
139 | Paraplegia (HP:0010550) | 1.69298355 |
140 | Prolonged QT interval (HP:0001657) | 1.69152144 |
141 | Spastic paraplegia (HP:0001258) | 1.69086092 |
142 | Protruding tongue (HP:0010808) | 1.67652655 |
143 | Spinal canal stenosis (HP:0003416) | 1.61285990 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK39 | 4.72430534 |
2 | OXSR1 | 3.40073303 |
3 | NTRK3 | 3.33859204 |
4 | EPHA4 | 3.12227187 |
5 | CDK19 | 2.45886255 |
6 | CASK | 2.30025870 |
7 | WNK1 | 2.28910651 |
8 | MAP3K9 | 2.23418890 |
9 | NTRK1 | 2.21226413 |
10 | WNK4 | 2.12180055 |
11 | EPHB1 | 2.04715655 |
12 | LATS2 | 1.94089354 |
13 | MINK1 | 1.91738936 |
14 | PNCK | 1.87828184 |
15 | PAK6 | 1.84218929 |
16 | MAP3K4 | 1.81894019 |
17 | TNIK | 1.80884623 |
18 | PRPF4B | 1.80732290 |
19 | MARK1 | 1.70142133 |
20 | BCR | 1.67647014 |
21 | PKN1 | 1.65616545 |
22 | SIK2 | 1.64815690 |
23 | RIPK1 | 1.62990261 |
24 | LIMK1 | 1.50064393 |
25 | DAPK1 | 1.48898986 |
26 | CAMK2B | 1.48615965 |
27 | MAP2K7 | 1.46738442 |
28 | UHMK1 | 1.46206608 |
29 | SGK494 | 1.40822065 |
30 | SGK223 | 1.40822065 |
31 | KSR2 | 1.40449058 |
32 | MAPKAPK5 | 1.40367062 |
33 | CDK5 | 1.34538443 |
34 | NEK6 | 1.30225636 |
35 | NTRK2 | 1.26933165 |
36 | ROCK2 | 1.23070832 |
37 | STK38 | 1.16446983 |
38 | PHKG1 | 1.16166802 |
39 | PHKG2 | 1.16166802 |
40 | FGFR2 | 1.14270186 |
41 | CAMK2A | 1.12937766 |
42 | MARK2 | 1.12895660 |
43 | CAMK2D | 1.11695471 |
44 | MUSK | 1.08035002 |
45 | ARAF | 1.07676787 |
46 | FGR | 1.07005831 |
47 | CSNK1G2 | 1.06874704 |
48 | MAPK13 | 1.05067303 |
49 | SGK2 | 1.04977148 |
50 | CAMK2G | 1.04932726 |
51 | ALK | 1.02361065 |
52 | MET | 0.99817344 |
53 | MAP2K4 | 0.99392292 |
54 | CSNK1G3 | 0.99255913 |
55 | CAMK4 | 0.96828024 |
56 | CSNK1A1L | 0.96374686 |
57 | PDPK1 | 0.94418634 |
58 | LMTK2 | 0.93167985 |
59 | CDK14 | 0.91376019 |
60 | PAK3 | 0.90365858 |
61 | CAMKK2 | 0.90135382 |
62 | MAP3K13 | 0.88096506 |
63 | CDK15 | 0.86203007 |
64 | DAPK2 | 0.85144836 |
65 | CDK18 | 0.84684606 |
66 | SGK3 | 0.82411414 |
67 | PRKCG | 0.81750896 |
68 | FES | 0.80709055 |
69 | MAP3K2 | 0.76536439 |
70 | TESK2 | 0.76127152 |
71 | TYRO3 | 0.75876780 |
72 | CDK11A | 0.74925357 |
73 | MAPK12 | 0.74131041 |
74 | ICK | 0.73568693 |
75 | PRKD3 | 0.71936188 |
76 | GRK5 | 0.70968600 |
77 | PRKCH | 0.69469502 |
78 | CAMKK1 | 0.69175822 |
79 | PDK1 | 0.68008474 |
80 | CSNK1G1 | 0.67280909 |
81 | PRKCE | 0.66412418 |
82 | RPS6KA3 | 0.64695527 |
83 | PBK | 0.64438197 |
84 | PLK2 | 0.64367250 |
85 | KSR1 | 0.63916682 |
86 | RIPK4 | 0.63415698 |
87 | PTK2B | 0.62560287 |
88 | GRK7 | 0.62203093 |
89 | STK11 | 0.62045799 |
90 | CAMK1 | 0.60965409 |
91 | ACVR1B | 0.60413040 |
92 | CLK1 | 0.57822552 |
93 | PRKCQ | 0.57254600 |
94 | FYN | 0.55673771 |
95 | CAMK1G | 0.53033850 |
96 | MAP3K12 | 0.51580303 |
97 | RET | 0.51491053 |
98 | PRKD1 | 0.50847114 |
99 | DYRK1A | 0.50805856 |
100 | PINK1 | 0.48972207 |
101 | CSNK1A1 | 0.48110589 |
102 | SGK1 | 0.48028413 |
103 | PRKG1 | 0.47624987 |
104 | BRSK1 | 0.47353862 |
105 | BRAF | 0.47218730 |
106 | PRKACB | 0.46802564 |
107 | ERBB4 | 0.46211002 |
108 | BMPR2 | 0.43317290 |
109 | MAP2K1 | 0.42475973 |
110 | CAMK1D | 0.42448720 |
111 | MAP2K6 | 0.41873383 |
112 | RAF1 | 0.41329166 |
113 | MAPK10 | 0.40868856 |
114 | CSNK1E | 0.39849881 |
115 | PRKCZ | 0.39481409 |
116 | TNK2 | 0.39412592 |
117 | TRPM7 | 0.37473850 |
118 | PRKACA | 0.36805960 |
119 | DYRK2 | 0.36344782 |
120 | DAPK3 | 0.35586416 |
121 | PRKCA | 0.32843900 |
122 | MAP3K11 | 0.31130574 |
123 | MAP3K1 | 0.29164498 |
124 | PRKCB | 0.28737009 |
125 | BMPR1B | 0.26831658 |
126 | CCNB1 | 0.26063693 |
127 | PRKG2 | 0.25835875 |
128 | CSNK1D | 0.25171243 |
129 | GSK3B | 0.24695711 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.90525931 |
2 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.48348753 |
3 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.43659575 |
4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.39852044 |
5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.39255486 |
6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.37013786 |
7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.24590773 |
8 | Morphine addiction_Homo sapiens_hsa05032 | 2.19607062 |
9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.06773597 |
10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.05261104 |
11 | Long-term potentiation_Homo sapiens_hsa04720 | 2.03438592 |
12 | Salivary secretion_Homo sapiens_hsa04970 | 1.92993892 |
13 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.91199069 |
14 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.83582942 |
15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.80955943 |
16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.79693366 |
17 | Axon guidance_Homo sapiens_hsa04360 | 1.74714133 |
18 | Long-term depression_Homo sapiens_hsa04730 | 1.72023530 |
19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.67381310 |
20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.67269564 |
21 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.65733745 |
22 | Taste transduction_Homo sapiens_hsa04742 | 1.62997187 |
23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.60909269 |
24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.58452875 |
25 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.56217596 |
26 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.42819192 |
27 | Insulin secretion_Homo sapiens_hsa04911 | 1.39738864 |
28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.37828269 |
29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.37538020 |
30 | Renin secretion_Homo sapiens_hsa04924 | 1.36338411 |
31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.35140551 |
32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.32112431 |
33 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.28615323 |
34 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.27015159 |
35 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.24626721 |
36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.19101314 |
37 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.18343745 |
38 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.18196116 |
39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.16081955 |
40 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.13416724 |
41 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.12046887 |
42 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.10972388 |
43 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.10918235 |
44 | Gap junction_Homo sapiens_hsa04540 | 1.08725165 |
45 | Alzheimers disease_Homo sapiens_hsa05010 | 1.06187293 |
46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.06027474 |
47 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.04111914 |
48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.04094015 |
49 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.03743730 |
50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.03245400 |
51 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.01290295 |
52 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.99246171 |
53 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.99053805 |
54 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.97481981 |
55 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.94715057 |
56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.93412976 |
57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92922050 |
58 | Phototransduction_Homo sapiens_hsa04744 | 0.88398822 |
59 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.86642104 |
60 | Parkinsons disease_Homo sapiens_hsa05012 | 0.83904702 |
61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.81485016 |
62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.78563479 |
63 | Melanogenesis_Homo sapiens_hsa04916 | 0.78469343 |
64 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.78241726 |
65 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.72877340 |
66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72819814 |
67 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.72292182 |
68 | Endocytosis_Homo sapiens_hsa04144 | 0.71641432 |
69 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.70644964 |
70 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.67997031 |
71 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.67479972 |
72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67135165 |
73 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.65967842 |
74 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.65780689 |
75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65710683 |
76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65647009 |
77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64454658 |
78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64255812 |
79 | Tight junction_Homo sapiens_hsa04530 | 0.64113424 |
80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.61921675 |
81 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61253167 |
82 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60374388 |
83 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.60340109 |
84 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.59886067 |
85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59205270 |
86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.59200994 |
87 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58960393 |
88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57290906 |
89 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.56337379 |
90 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55621183 |
91 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54620298 |
92 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52467835 |
93 | Prion diseases_Homo sapiens_hsa05020 | 0.51756783 |
94 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.50411003 |
95 | Glioma_Homo sapiens_hsa05214 | 0.50366221 |
96 | Mineral absorption_Homo sapiens_hsa04978 | 0.48307840 |
97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47665032 |
98 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.47374586 |
99 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.42962213 |
100 | Bile secretion_Homo sapiens_hsa04976 | 0.41594599 |
101 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41068572 |
102 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40420676 |
103 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.40086043 |
104 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39264977 |
105 | Huntingtons disease_Homo sapiens_hsa05016 | 0.39179654 |
106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38996052 |
107 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.38740052 |
108 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38715013 |
109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37558952 |
110 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36017542 |
111 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.35414877 |
112 | Alcoholism_Homo sapiens_hsa05034 | 0.34478541 |
113 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34182194 |
114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31338205 |
115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.27088222 |
116 | ABC transporters_Homo sapiens_hsa02010 | 0.26730910 |
117 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.24721515 |
118 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.22960299 |
119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.21359952 |
120 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.19627892 |
121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.17222039 |
122 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.17200376 |
123 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.16738474 |